CEL-SCI (CVM) CSO Talor Eyal Receives 250,000 Share Award

What Happened
Talor Eyal, Chief Scientific Officer of CEL‑SCI Corp. (CVM), was granted a derivative award for 250,000 shares on 2026-08-14 at an exercise/strike price of $0.01 per share, reflecting a nominal grant value of $2,500. This was an award/grant (not an open‑market purchase or sale) and is compensation rather than a straightforward purchase signal.

Key Details

• Transaction date: 2026-08-14; Form 4 filed: 2026-08-17 (filing appears timely under the SEC’s 2-business-day rule).
• Grant: 250,000 derivative shares at $0.01 per share; reported aggregate value = $2,500.
• Shares owned after transaction: Not specified in the provided data.
• Footnote: The award vests in three equal annual installments beginning one year after the grant date (per filing footnote F1).
• Transaction code: A (grant/award/acquisition of derivative securities).

Context
This appears to be a compensatory derivative grant (likely stock options or similar) that vests over three years, so the recipient cannot fully benefit immediately. The reported $2,500 reflects the grant price times shares; actual future value depends on CEL‑SCI’s stock performance. Grants are common insider compensation and do not, by themselves, indicate a buy or sell signal.